Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
3. Webb L. Dental Anesthesia: Overview of Injectable Agents Useful for Nonsurgical Periodontal Therapy. Available at https://www.rdhmag.com/articles/print/volume-36/issue-1/contents/understanding-available-agents.html. Last accessed August 20, 2021.
4. Henderson S. Drug interactions with local anaesthetic preparations used by primary care dental practitioners. Dent Update. 2010;37(4):236-238, 241.
5. Malamed SF. Up Close With Amide Anesthetic Agents. Available at https://dimensionsofdentalhygiene.com/article/up-close/. Last accessed August 20, 2021.
7. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 26th ed. Hudson, OH: LexiComp; 2021.
10. Uckan S, Dayangac E, Araz K. Is permanent maxillary tooth removal without palatal injection possible? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(6):733-735.
11. Yadav S. Anesthetic success of supplemental infiltration in mandibular molars with irreversible pulpitis: a systematic review.J Conserv Dent. 2015;18(3):182-186.
12. Ashraf H, Kazem M, Dianat O, Noghrehkar F. Efficacy of articaine versus lidocaine in block and infiltration anesthesia administered in teeth with irreversible pulpitis: a prospective, randomized, double-blind study. J Endod. 2013;39(1):6-10.
13. Parirokh M, Yosefi MH, Nakhaee N, Abbott PV, Manochehrifar H. The success rate of bupivacaine and lidocaine as anesthetic agents in inferior alveolar nerve block in teeth with irreversible pulpitis without spontaneous pain. Restor Dent Endod. 2015;40(2):155-160.
14. Pogrel MA. Permanent nerve damage from the inferior alveolar nerve blocks: an update to include articaine. J Calif Dent Assoc. 2007;35(4):271-273.
15. Pogrel MA, Permanent nerve damage from inferior alveolar nerve blocks: a current update. J Calif Dent Assoc. 2012;40(10):795-797.
16. Kakroudi SH, Mehta S, Millar BJ. Articaine hydrochloride: is it the solution? Dent Update. 2015;42(1):88-90.
17. Yagiela JA. Local anesthetics. In: Dionne RA, Phero JP, Becker DE (eds). Management of Pain and Anxiety in the Dental Office: Oral and Maxillofacial. St. Louis, MO: WB Saunders; 2002.
18. LexiComp Online. Available at https://online.lexi.com. Last accessed August 20, 2021.
19. Kreeftenberg HG Jr, Braams R, Nauta P. Methemoglobinemia after low-dose prilocaine in an adult patient receiving barbiturate comedication. Anesth Analg. 2007;104(2):459-460.
20. MedicineNet. Acetaminophen Uses, Side Effects, and Dosage. Available at https://www.medicinenet.com/acetaminophen/article.htm. Last accessed August 20, 2021.
21. International Ibuprofen Foundation. Non-Prescription Use of Ibuprofen and the Risks of Gastrointestinal and Renal Toxicity. Available at https://wayback.archive-it.org/7993/20170405155048/https://www.fda.gov/ohrms/dockets/ac/02/briefing/3882B2_06_International%20Ibuprofen%20Foundation.htm. Last accessed August 20, 2021.
22. MedicineNet.com. FDA Makes Statement on Naproxen (Aleve). Available at https://www.medicinenet.com/script/main/art.asp?articlekey=41145. Last accessed August 20, 2021.
23. Yaksh T, Wallace M. Section II: Neuropharmacology. Chapter 20: Opioids, Analgesia, and Pain Management. In: Brunton LL, Hilal-Dandan R, Knollmann BC (eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics. 13th ed. New York, NY: McGraw-Hill; 2018.
24. Vree TB, van Dongen RT, Koopman-Kimenai PM. Codeine analgesia is due to codeine-6-glucuronide, not morphine. Int J Clin Pract. 2000;54(6):395-398.
25. Golubic S, Moore PA, Katz N, Kenna GA, Hersh EV. Opioid prescribing in dentistry: trends, ethical considerations, and diversion and abuse prevention. Inside Dent. 2011;7(6):51-58.
26. Denisco RC, Kenna GA, O'Neil MG, et al. Prevention of prescription opioid abuse: the role of the dentist. JADA. 2011;142(7):800-810.
27. McCauley JL, Leite RS, Gordan VV, et al. Opioid prescribing and risk mitigation implementation in the management of acute pain: results from The National Dental Practice-Based Research Network. JADA. 2018;149(5):353-362.
28. McCauley JL, Leite RS, Melvin CL, Fillingim RB, Brady KT. Dental opioid prescribing practices and risk mitigation strategy implementation: identification of potential targets for provider-level intervention. Subst Abus. 2016;37(1):9-14.
29. Sinatra RS, Jahr JS, Watkins-Pitchford JM (eds). The Essence of Analgesia and Analgesics. Cambridge: Cambridge University Press; 2011.
30. Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther. 2006;79(5):461-479.
31. Drugs.com. Oxycodone. Available at https://www.drugs.com/monograph/oxycodone.html. Last accessed August 20, 2021.
32. Gross AE, Hanna D, Rowan SA, Bleasdale SC, Suda KJ. Successful implementation of an antibiotic stewardship program in an academic dental practice. Open Forum Infect Dis. 2019;6(3):1-6.
33. Suda KJ, Henschel H, Patel U, Fitzpatrick MA, Evans CT. Use of antibiotic prophylaxis for tooth extractions, dental implants, and periodontal surgical procedures. Open Forum Infect Dis. 2018;5(1):1-5.
34. Loffler C, Bohmer F. The effect of interventions aiming to optimize the prescription of antibiotics in dental care: a systematic review. PLoS One. 2017;12(11):1-23.
35. Lockhart PB, Tampi MP, Abt E, et al. Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling: a report from the American Dental Association. JADA. 2019;150(11):906-921.
36. Centers for Disease Control and Prevention Antibiotic/Antimicrobial Resistance (AR/AMR): The AMR Challenge. Available at https://www.cdc.gov/drugresistance/intl-activities/amr-challenge.html. Last accessed August 20, 2021.
37. Bellis M. The History of Penicillin. Available at https://www.thoughtco.com/history-of-penicillin-1992304. Last accessed August 20, 2021.
38. Solensky R. Hypersensitivity reactions to beta-lactamantibiotics. Clin Rev Allergy Immunol. 2003;24(3):201-220.
39. Mailänder-Sánchez D, Wagener J, Schaller M. Potential role of probiotic bacteria in the treatment and prevention of localised candidosis. Mycoses. 2012;55(1):17-26.
40. PubChem Compound. Penicillin V. Available at https://pubchem.ncbi.nlm.nih.gov/compound/6869. Last accessed August 20, 2021.
41. Sandor GK, Low DE, Judd PL, Davidson RJ. Antimicrobial treatment options in the management of odontogenic infections.J Can Dent Assoc. 1998;64(7):508-514.
42. Topazian RG, Goldberg MH, Hupp JR (eds). Oral and Maxillofacial Infections. 4th ed. Philadelphia, PA: WB Saunders; 2002.
43. Public Health Agency of Canada. Human Antimicrobial Drug Use Report 2012/2013. Available at https://publications.gc.ca/collections/collection_2014/aspc-phac/HP37-20-2013-eng.pdf. Last accessed August 20, 2021.
44. The Merck Manual. Lincosamides, Oxazolidinones, and Streptogramins. Available at https://www.merckmanuals.com/professional/infectious-diseases/bacteria-and-antibacterial-drugs/lincosamides%2C-oxazolidinones%2C-and-streptogramins. Last accessed August 20, 2021.
45. Newman MG, van Winkelhoff AJ (eds). Antibiotic and Antimicrobial Use in Dental Practice. 2nd ed. Chicago, IL: Quintessence; 2001.
46. Brook I, Lewis MA, Sándor GK, Jeffcoat M, Samaranayke LP, Vera Rojas J. Clindamycin in dentistry: more than just an effective prophylaxis for endocarditis? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(5):550-558.
47. Mayo Clinic. Periodontitis. Available at https://www.mayoclinic.org/diseases-conditions/periodontitis/symptoms-causes/syc-20354473. Last accessed August 20, 2021.
48. RxList. Actisite. Available at https://www.rxlist.com/actisite-drug.htm. Last accessed August 20, 2021.
49. Medical Wellness Center. Frequently Asked Questions: Periostat. Available at https://www.medicalwellnesscenter.com/Periostatquestionsandanswers.htm. Last accessed August 20, 2021.
50. Drugs.com. Arestin. Available at https://www.drugs.com/pro/arestin.html. Last accessed August 20, 2021.
51. Centers for Disease Control and Prevention. Fungal Diseases. Candida Infections of the Mouth, Throat, and Esophagus. Available at https://www.cdc.gov/fungal/diseases/candidiasis/thrush/index.html. Last accessed August 20, 2021.
52. Berberi A, Noujeim Z, Aoun G. Epidemiology of oropharyngeal candidiasis in human immunodeficiency virus/acquired immune deficiency syndrome patients and CD4+ counts. J Int Oral Health. 2015;7(3):20-23.
53. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50.
54. American Dental Association. The ADA/PDR Guide to Dental Therapeutics. 5th ed. Montvale, NJ: PDR Network; 2009.
55. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA Limits Usage of Nizoral (ketoconazole) Oral Tablets Due to Potentially Fatal Liver Injury and the Risk of Drug Interactions and Adrenal Gland Problems. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-limits-usage-nizoral-ketoconazole-oral-tablets-due-potentially. Last accessed August 20, 2021.
56. World Health Organization. WHO Model List of Essential Medicines. Available at https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists. Last accessed August 20, 2021.
57. Little JW, Falace DA, Miller CS, Rhodus NL. Little and Falace's Dental Management of the Medically Compromised Patient. 8th ed. St. Louis, MO: Mosby; 2012. 9th ed. St. Louis, MO: Mosby; 2018.
58. Donaldson M, Goodchild JH. Maximum cumulative doses of sedation medication for in-office use. Gen Dent. 2007;55(2):143-148.
59. Farinde A. Benzodiazepine Equivalency Chart. Available at https://emedicine.medscape.com/article/2172250-overview. Last accessed August 20, 2021.
60. Goerig M, Schulte am Esch J. History of nitrous oxide with special reference to its early use in Germany. Best Pract Res Clin Anesthesiol. 2001;15(3):313-338.
61. Dental Assisting National Board, Inc. California State Requirements. Additional Resources. Allowable and Prohibited Duties for Each Level (PDF). Available at https://www.danb.org/Meet-State-Requirements/State-Specific-Information/California.aspx. Last accessed August 20, 2021.
62. Goldhirsch A, Gelber RD, Tattersall MN, Rudenstam CM, Cavalli F. Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancer. Lancet. 1987;2(8551):151.
63. van Outryve S, Schrijvers D, van den Brande J, et al. Methotrexate-associated liver toxicity in a patient with breast cancer: case report and literature review. Neth J Med. 2002;60(5):216-222.
64. Silverman M, Hexem J. Nitrous oxide/oxygen sedation and the single-dose sedative. Inside Dent. 2011;7(8):42-54.
65. Federal Register. Content and Format of Labeling for Human Prescription Drug and Biological Products: Requirements for Pregnancy and Lactation Labeling. Available at https://www.federalregister.gov/articles/2014/12/04/2014-28241/content-andformat-of-labeling-for-human-prescription-drug-and-biological-products-requirements-for. Last accessed August 20, 2021.
66. Gaffney A. FDA Scraps Pregnancy Labeling Classification System in Favor of New Standard. Available at https://www.raps.org/regulatory-focus%e2%84%a2/news-articles/2014/12/fda-scraps-pregnancy-labeling-classification-system-in-favor-of-new-standard. Last accessed August 20, 2021.
67. U.S. Food and Drug Administration. Pregnancy and Lactation Labeling (Drugs) Final Rule. Available at https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule. Last accessed August 20, 2021.
68. U.S. Food and Drug Administration. Press Release [Archive]. FDA Issues Final Rule on Changes to Pregnancy and Lactation Labeling Information for Prescription Drug and Biological Products. Available at https://wayback.archive-it.org/7993/20170111093956/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317.htm. Last accessed August 20, 2021.
69. Federal Register. Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products—Content and Format; Draft Guidance for Industry; Availability. Available at https://www.federalregister.gov/documents/2020/07/30/2020-16530/pregnancy-lactation-and-reproductive-potential-labeling-for-human-prescription-drug-and-biological. Last accessed August 20, 2021.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.